Clinical Trial Update: Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults. [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update reporting antibody responses to pneumococcal vaccines in adults with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumococcal Infection

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED